SCHRODER INVESTMENT MANAGEMENT GROUP
Position in CSTL — Castle Biosciences Inc
CIK 1086619
London, X0
Position in CSTL
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$7,339,001
-$11,806,061 QoQ
Shares Held
298,941
-39.3% QoQ
Ownership
0.979%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CSTL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026SCHRODER INVESTMENT MANAGEMENT GROUP holds $1,701,017,130 across 14 Diagnostics & Research names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
1,525,255 | $764,701,841 | |
| 2 | WAT |
Waters Corp /De/
|
1,264,226 | $474,135,314 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
198,974 | $104,747,870 | |
| 4 | DGX |
Quest Diagnostics Inc
|
417,715 | $88,534,693 | |
| 5 | DHR |
Danaher Corp /De/
|
348,309 | $66,345,897 | |
| 6 | NEO |
Neogenomics Inc
|
4,342,883 | $63,362,662 | |
| 7 | MTD |
Mettler Toledo International Inc/
|
34,110 | $43,575,865 | |
| 8 | GH |
Guardant Health, Inc.
|
210,541 | $31,587,466 |
All Filings in CSTL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,339,001 | 298,941 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $19,145,062 | 492,161 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $11,270,011 | 494,950 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $13,243,840 | 648,572 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $11,953,721 | 597,089 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||